Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kosta Tsaparikos"'
Autor:
Tod Smeal, Sophia Randolph, Michelle Sands, Natilie Hosea, Jitesh P. Jani, Kosta Tsaparikos, Anthony Wong, Robert H. Denlinger, Richard Ding, Ming Qiu, Marlena Walls, Ping Wei
Supplementary Table 1 from Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::531316747872a29ea858a532f969d478
https://doi.org/10.1158/1535-7163.22485564.v1
https://doi.org/10.1158/1535-7163.22485564.v1
Autor:
Tod Smeal, Sophia Randolph, Michelle Sands, Natilie Hosea, Jitesh P. Jani, Kosta Tsaparikos, Anthony Wong, Robert H. Denlinger, Richard Ding, Ming Qiu, Marlena Walls, Ping Wei
Supplementary Table 3 from Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7315adbd91a399cb9602bf1dc894286a
https://doi.org/10.1158/1535-7163.22485558
https://doi.org/10.1158/1535-7163.22485558
Autor:
Tod Smeal, Sophia Randolph, Michelle Sands, Natilie Hosea, Jitesh P. Jani, Kosta Tsaparikos, Anthony Wong, Robert H. Denlinger, Richard Ding, Ming Qiu, Marlena Walls, Ping Wei
Supplementary Figures 1-4 from Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a89a3d9bd2a99f57b17a438a128f492d
https://doi.org/10.1158/1535-7163.22485567.v1
https://doi.org/10.1158/1535-7163.22485567.v1
Autor:
Tod Smeal, Sophia Randolph, Michelle Sands, Natilie Hosea, Jitesh P. Jani, Kosta Tsaparikos, Anthony Wong, Robert H. Denlinger, Richard Ding, Ming Qiu, Marlena Walls, Ping Wei
Supplementary Table 2 from Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b07ce884b1cecb1dc5ec41a9f5292d
https://doi.org/10.1158/1535-7163.22485561.v1
https://doi.org/10.1158/1535-7163.22485561.v1
Autor:
Tod Smeal, Sophia Randolph, Michelle Sands, Natilie Hosea, Jitesh P. Jani, Kosta Tsaparikos, Anthony Wong, Robert H. Denlinger, Richard Ding, Ming Qiu, Marlena Walls, Ping Wei
Aberrant regulation of Notch signaling has been implicated in tumorigenesis. Proteolytic release of the Notch intracellular domain (NICD) by γ-secretase plays a key role in Notch-dependent nuclear signaling. γ-Secretase is an attractive pharmaceuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d775370b00baf4a1ae990ef2aa583ef
https://doi.org/10.1158/1535-7163.c.6531999
https://doi.org/10.1158/1535-7163.c.6531999
Autor:
Kosta Tsaparikos, Robert H. Denlinger, Marlena Walls, Sophia Randolph, Michelle Sands, Ping Wei, Anthony C. Wong, Ming Qiu, Natilie Hosea, Richard Ding, Tod Smeal, Jitesh P. Jani
Publikováno v:
Molecular Cancer Therapeutics. 9:1618-1628
Aberrant regulation of Notch signaling has been implicated in tumorigenesis. Proteolytic release of the Notch intracellular domain (NICD) by γ-secretase plays a key role in Notch-dependent nuclear signaling. γ-Secretase is an attractive pharmaceuti